show dates: November 23-25, 2026
location: Yashobhoomi (India International Convention and Expo Centre) - New Delhi
hall 1: booth 1I02 (Barentz India)
hall 2: booth G26 (DPB)
Join Ashland at CPHI India 2026 and discover how we are expanding the possibilities of pharmaceutical formulation. From enabling oral biologics and GLP-1 therapies to advancing injectables and oral solid dosage forms, our growing portfolio of exceptional excipients is designed to help formulators overcome complexity with confidence.
Explore our newest product introductions, including permexa™ sodium caprate, enabling oral biologics and peptide delivery; lubrify™ sodium stearyl fumarate, supporting efficient manufacturing processes; and vialose™ mannitol, expanding our injectable and biologics platform.
Together with our trusted portfolio of cellulosics, acetylenics, film coatings, bioresorbable polymers and highly purified sugars, these new additions demonstrate Ashland's commitment to helping customers bring the next generation of therapies to life.
Visit us to discuss your projects and formulation challenges.
learn more about the ways we are always solving™.
Ashland offers a broad selection of pharmaceutical excipients to formulate effective pharmaceutical products. Well-known for our cellulosics and acetylenics, Ashland also offers film coating solutions and an expanded portfolio for injectables and biologics. The robust Ashland pharmaceutical portfolio includes immediate and controlled release excipients, film coating systems, bioresorbable polymers for long-acting injectables and lyoprotectants—supporting many of your formulation needs.
key products